ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,161,000 | -2.5% | 10,473 | -4.9% | 0.01% | -13.3% |
| Q4 2020 | $3,241,000 | +23.1% | 11,016 | +9.9% | 0.02% | -11.8% |
| Q3 2020 | $2,632,000 | -14.4% | 10,027 | -26.5% | 0.02% | -15.0% |
| Q2 2020 | $3,074,000 | -55.7% | 13,649 | -74.1% | 0.02% | -62.3% |
| Q1 2020 | $6,935,000 | -71.3% | 52,648 | -65.1% | 0.05% | -54.7% |
| Q4 2019 | $24,203,000 | +39.3% | 150,783 | -1.1% | 0.12% | +18.2% |
| Q3 2019 | $17,373,000 | -24.1% | 152,444 | -5.7% | 0.10% | -30.3% |
| Q2 2019 | $22,885,000 | -58.7% | 161,638 | -63.6% | 0.14% | -27.6% |
| Q1 2019 | $55,410,000 | +1876.1% | 443,854 | +1100.1% | 0.20% | +1860.0% |
| Q3 2018 | $2,804,000 | +140.5% | 36,984 | +155.1% | 0.01% | +66.7% |
| Q1 2018 | $1,166,000 | – | 14,497 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |